BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dantas PHDS, Matos AO, da Silva Filho E, Silva-Sales M, Sales-Campos H. Triggering receptor expressed on myeloid cells-1 (TREM-1) as a therapeutic target in infectious and noninfectious disease: a critical review. Int Rev Immunol 2020;39:188-202. [PMID: 32379561 DOI: 10.1080/08830185.2020.1762597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Singh H, Rai V, Nooti SK, Agrawal DK. Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates. Expert Opin Ther Pat 2021;31:549-61. [PMID: 33507843 DOI: 10.1080/13543776.2021.1883587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kerget F, Kerget B, İba Yılmaz S, Kızıltunç A. Evaluation of the relationship between TREM-1/TREM-2 ratio and clinical course in COVID-19 pneumonia. Int J Clin Pract 2021;:e14697. [PMID: 34365706 DOI: 10.1111/ijcp.14697] [Reference Citation Analysis]
3 Dholariya S, Parchwani DN, Singh R, Radadiya M, Katoch CDS. Utility of P-SEP, sTREM-1 and suPAR as Novel Sepsis Biomarkers in SARS-CoV-2 Infection. Indian J Clin Biochem 2021;:1-8. [PMID: 34642555 DOI: 10.1007/s12291-021-01008-6] [Reference Citation Analysis]
4 da Silva-Neto PV, de Carvalho JCS, Pimentel VE, Pérez MM, Toro DM, Fraga-Silva TFC, Fuzo CA, Oliveira CNS, Rodrigues LC, Argolo JGM, Carmona-Garcia I, Neto NT, Souza COS, Fernandes TM, Bastos VAF, Degiovani AM, Constant LF, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, da Rocha JJR, Feres O, Frantz FG, Gerlach RF, Maruyama SR, Russo EMS, Viana AL, Fernandes APM, Santos IKFM, Bonato VLD, Boechat AL, Malheiro A, Sadikot RT, Dias-Baruffi M, Cardoso CRB, Faccioli LH, Sorgi CA, On Behalf Of The Imunocovid Study Group. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity. Viruses 2021;13:2521. [PMID: 34960790 DOI: 10.3390/v13122521] [Reference Citation Analysis]
5 Ates D, Doner HC, Kurban S, Koksal H. The Effect of Soluble TREM-1 in Idiopathic Granulomatous Mastitis. Immunol Invest 2021;:1-12. [PMID: 33522329 DOI: 10.1080/08820139.2021.1879846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang JB, Chen NC, Chen CL, Fu MH, Pan HY, Hsu CY, Chen SD, Chuang YC. Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 Associated with the Severity and Outcome of Acute Ischemic Stroke. J Clin Med 2020;10:E61. [PMID: 33375339 DOI: 10.3390/jcm10010061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Raggi F, Bosco MC. Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1). Cancers (Basel) 2020;12:E1337. [PMID: 32456204 DOI: 10.3390/cancers12051337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]